P1106: PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS)

ABSTRACT:

SUBMITTER: Sun M 

PROVIDER: S-EPMC9430675 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature